TPST (Tempest Therapeutics) Pangali Forward P/E
The forward P/E ratio for Tempest Therapeutics (TPST) demonstrates a price corridor where the 0.00 mark characterizes this parameter. Cancer therapy risks are extreme due to pressure from resource behemoths. Geopolitics complicates cross-border cooperation and the patent protection of technologies. The success of Tempest Therapeutics is based on clinical data that determine its position in the high-margin targeted drug segment.
Ringkesan rincian data analitis Tempest Therapeutics Corp (TPST)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Tempest Therapeutics|TPST - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Tempest Therapeutics|TPST - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Tempest Therapeutics Inc|TPST - Utang jangka dawa|Utang jangka cendhak perusahaan Tempest Therapeutics|Likuiditas cepet tempesttx.com
- rincian asil keuangan lan kelipatan valuasi:
TPST - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep Tempest Therapeutics|TPST - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Tempest Tx|TPST - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tempest Therapeutics Inc|TPST - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Tempest Therapeutics|TPST - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan tempesttx.com|TPST - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Tempest Therapeutics
Ringkesan analisis perusahaan:Tempest Therapeutics, Inc.
Forward P/E measures the market value of every dollar of expected earnings, allowing an investor to assess the extent of the premium paid for future financial results based on current guidance. Analyzing the forward P/E multiple for Tempest Therapeutics (TPST) reveals how the exclusivity of patents for anti-cancer compounds and high FDA barriers protect future cash flows from competition, justifying the current capitalization.
Pesaing Tempest Therapeutics (TPST)
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Therapeutics)|Rasio kapitalisasi marang bathi mangsa ngarep AURA|Pangali Forward P/E CADL (Candel Therapeutics, Inc.)|Accuray Inc (ARAY) - Rasio prakiraan rega marang bathi|SLS - Rega marang bathi mangsa ngarep|Actuate Therapeutics Inc (ACTU) - Prakiraan rega marang bathi|Citius Oncology, Inc. (CTOR) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake HURA (TuHURA Biosciences)|TARA (Protara Therapeutics, Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Fate Therapeutics Inc FATE|Rega marang bathi mangsa ngarep Aadi Bioscience Inc (WHWK)|Kapitalisasi marang proyeksi bathi tscan.com|Champions Oncology, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep XBIT (XBiotech Inc)|CVM: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi OSTX (OS Therapies Inc.)|RADX (Radiopharm Theranostics Limited) - Prakiraan rega marang bathi|ARTV: Rasio kapitalisasi marang bathi mangsa ngarep|ANL (Adlai Nortye Ltd) - Pangali Forward P/E|VERU: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E XLO|RENB - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Mural Oncology MURA|Pangali mangsa ngarep rega marang bathi KAPA|OnKure - Pangali Forward P/E|GDTC - Pangali Forward P/E|curis.com (CRIS) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake APLM (Apollomics)|THAR (Tharimmune Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Advanced Biomed Corp ADVB|Prakiraan rega marang bathi GNPX (Genprex, Inc.)|Pangali Forward P/E calidibio.com (CLDI)|Sunshine Biopharma, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep XBIO (Xenetic Biosciences Inc.)|Salarius - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Kitov Pharma PPBT|AONC: Pangali Forward P/E|Prakiraan rega marang bathi beigene.com|Rega marang bathi mangsa ngarep Checkpoint Therapeutics, Inc.|elevationoncology.com (ELEV) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi ICAD (iCAD, Inc.)|Rasio kapitalisasi marang bathi mangsa ngarep IKNA|Rega marang bathi mangsa ngarep Notable Labs, Ltd. NTBL|VIRX (Viracta Therapeutics Inc.) - Rasio rega marang bathi sing dikarepake|MOR - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi NAYA Biosciences Inc NAYA|AAPGV (Ascentage Pharma Group Ltd) - Prakiraan rega marang bathi
